Edmondson Frazor Titus III
SEC CIK 1835780 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZLAB | Zai Lab Ltd | CLO | 30.3K | — | $2.99M | 44 | 2021-08-17 | 2026-06-26 |
Most active insiders at ZLAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Du Ying | COB, CEO, Dir | — | $8.58M |
| 2 | Edmondson Frazor Titus III | CLO | — | $1.01M |
| 3 | Amado Rafael | See Remarks | — | $675.0K |
| 4 | Lis William | Dir | — | $340.0K |
| 5 | Smiley Joshua L | See Remarks | — | $294.3K |
| 6 | Chen Yajing | CFO | — | $239.3K |
| 7 | GAYNOR RICHARD | Dir | $65.8K | — |
| 8 | Leung Nisa | Dir | — | — |
| 9 | Vounatsos Michel | Dir | — | — |
| 10 | Morrison Scott W | Dir | — | — |
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-29 16:18 | 2026-06-25 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +14.6K | 34.4K | +74% | — |
| D | 2026-06-29 16:18 | 2026-06-26 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $17.46 | -4,103 | 30.3K | -12% | -$71.6K |
| T | 2026-05-15 16:46 | 2026-05-14 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $20.19 | -3,517 | 19.8K | -15% | -$71.0K |
| 2026-04-08 19:34 | 2026-04-06 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $20.45 | -1,224 | 23.4K | -5% | -$25.0K | |
| DM | 2026-04-03 17:58 | 2026-04-01+ | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +22.3K | 28.8K | +343% | — |
| D | 2026-04-03 17:58 | 2026-04-02 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $20.39 | -4,194 | 24.6K | -15% | -$85.5K |
| D | 2026-03-16 | 2026-03-12 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +4,258 | 7,775 | +121% | — |
| D | 2026-03-16 | 2026-03-13 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $18.63 | -1,281 | 6,494 | -16% | -$23.9K |
| T | 2026-03-06 | 2026-03-05 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $19.06 | -15.6K | 3,517 | -82% | -$296.7K |
| T | 2025-12-18 | 2025-12-16 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $17.14 | -8,651 | 19.1K | -31% | -$148.3K |
| T | 2025-11-25 | 2025-11-21 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $19.78 | -14.3K | 27.7K | -34% | -$283.4K |
| D | 2025-08-19 | 2025-08-15 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +4,850 | 43.9K | +12% | — |
| D | 2025-08-19 | 2025-08-18 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $36.24 | -1,883 | 42.1K | -4% | -$68.2K |
| D | 2025-06-27 | 2025-06-25 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +14.6K | 45.0K | +48% | — |
| D | 2025-06-27 | 2025-06-26 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $36.13 | -5,877 | 39.1K | -13% | -$212.3K |
| D | 2025-04-07 | 2025-04-04 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $33.11 | -1,874 | 30.4K | -6% | -$62.0K |
| D | 2025-04-07 | 2025-04-03 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +5,032 | 32.2K | +18% | — |
| DM | 2025-04-03 | 2025-04-01 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +17.3K | 17.0K | New | — |
| D | 2025-04-03 | 2025-04-02 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $35.89 | -4,369 | 27.2K | -14% | -$156.8K |
| T | 2025-03-04 | 2025-02-28 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $32.98 | -14.5K | 14.3K | -50% | -$479.7K |
| D | 2024-08-20 | 2024-08-16 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +4,850 | 30.8K | +19% | — |
| D | 2024-08-20 | 2024-08-19 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $16.95 | -1,924 | 28.9K | -6% | -$32.6K |
| D | 2024-06-27 | 2024-06-25 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +14.6K | 31.0K | +89% | — |
| D | 2024-06-27 | 2024-06-26 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $17.90 | -5,062 | 25.9K | -16% | -$90.6K |
| T | 2024-05-16 | 2024-05-14 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $21.33 | -10.0K | 16.4K | -38% | -$213.3K |
| D | 2024-04-05 | 2024-04-03 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | $15.90 | +5,031 | 27.7K | +22% | +$80.0K |
| D | 2024-04-05 | 2024-04-04 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $15.67 | -1,244 | 26.4K | -4% | -$19.5K |
| DM | 2024-04-03 | 2024-04-01 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | $16.72 | +3,501 | 23.5K | +18% | +$58.5K |
| DM | 2024-04-03 | 2024-04-02 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $16.15 | -885 | 22.8K | -4% | -$14.3K |
| T | 2024-03-19 | 2024-03-15 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $18.71 | -10.0K | 20.0K | -33% | -$187.1K |
| D | 2024-01-03 | 2024-01-03 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale+OE | $26.12 | -4,803 | 30.0K | -14% | -$125.5K |
| D | 2024-01-03 | 2024-01-01 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +17.5K | 34.8K | +102% | — |
| D | 2023-08-21 | 2023-08-17 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | F - Tax | $23.39 | -1,181 | 17.3K | -6% | -$27.6K |
| D | 2023-08-21 | 2023-08-17 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | — | +4,850 | 18.4K | +36% | — |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | $25.30 | +14.6K | 36.5K | +67% | +$369.4K |
| D | 2023-06-26 | 2023-06-23 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | F - Tax | $25.30 | -3,556 | 33.0K | -10% | -$90.0K |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | F - Tax | $33.26 | -953 | 21.9K | -4% | -$31.7K |
| DM | 2023-04-03 | 2023-03-31 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | $33.26 | +3,500 | 22.7K | +18% | +$116.4K |
| 2023-03-07 | 2023-03-06 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | S - Sale | $40.55 | -7,965 | 19.4K | -29% | -$323.0K | |
| A | 2022-08-22 | 2022-04-01 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | F - Tax | $45.47 | -203 | 23.7K | -0.8% | -$9,230 |
| D | 2022-08-19 | 2022-08-17 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | $43.52 | +4,850 | 9,146 | +113% | +$211.1K |
| D | 2022-08-19 | 2022-08-17 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | F - Tax | $43.52 | -1,181 | 7,965 | -13% | -$51.4K |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | M - OptEx | $0.00 | +830 | 23.9K | +4% | $0 |
| 2021-12-03 | 2021-08-17 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | CLO | F - Tax | $140.29 | -1,181 | 23.1K | -5% | -$165.7K |
Purchase Sale Sale after option exercise All abbreviations